AKUMS / NSE / Biotechnology & Drugs
Akums Drugs and Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High599.4
Target Low410.1
Target Mean1.33
Target Median41.67
Risk Metrics
Overall RiskBalanced risk
Board Risk33.72
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE Upstox
Akums Drugs and Pharmaceuticals to attend investor meets on June 15 scanx.trade
Akums Drugs and Pharmaceuticals to host InsightX 2026 virtual meet scanx.trade
Akums Receives European CEP Approval for Cefpodoxime Proxetil IndiaMedToday
Akums Drugs and Pharmaceuticals to host investor meet on June 8 scanx.trade
Akums secures European CEP approval for Cefpodoxime Proxetil Indian Pharma Post
Akums receives EDQM CEP approval for Cefpodoxime Proxetil API Express Pharma
Akums Drugs and Pharma IPO listing: Shares list at 6.7% premium to issue price on NSE & BSE Upstox
© SharekeyX | Rusaka Technologies 2024-2026